Margulies L J
University of California, Davis, USA.
Curr Opin Ophthalmol. 1994 Dec;5(6):99-104. doi: 10.1097/00055735-199412000-00016.
The past year's important advancements in the ocular manifestations of cardiovascular and hematologic diseases are reviewed. Systemic changes related to blood pressure and carotid artery disease are commonly manifested on the ophthalmic examination. Ocular ischemic changes have been observed in patients with unusual aortic or congenital cardiac disorders. The ophthalmologist plays an important role in the detection of patients who are at risk for cardiovascular and cerebrovascular events. The hematologic disorders affecting the eye are subdivided into benign and malignant categories. A spectrum of diseases that include sickle cell hemoglobinopathy, aplastic anemia, leukemia, lymphoma, and multiple myeloma are discussed. With increased patient survival time after bone marrow transplantation, secondary ophthalmic complications are being identified. Although the ocular findings in the hematologic maladies are diverse, they may be an indication of serious systemic complications and have significant visual consequences.
本文回顾了过去一年心血管和血液系统疾病眼部表现的重要进展。与血压和颈动脉疾病相关的全身变化通常在眼科检查中表现出来。在患有特殊主动脉或先天性心脏疾病的患者中观察到眼部缺血性变化。眼科医生在检测有心血管和脑血管事件风险的患者中发挥着重要作用。影响眼睛的血液系统疾病分为良性和恶性两类。讨论了一系列疾病,包括镰状细胞血红蛋白病、再生障碍性贫血、白血病、淋巴瘤和多发性骨髓瘤。随着骨髓移植后患者存活时间的增加,继发性眼科并发症正在被识别出来。尽管血液系统疾病的眼部表现多种多样,但它们可能是严重全身并发症的迹象,并会产生重大的视觉后果。